Skip to content

Ethical Concerns about Psilocybin Intellectual Property

Konstantin Gerber, Inti García Flores, Angela Christina Ruiz, Ismail L. Ali, Natalie Lyla Ginsberg, Eduardo Ekman Schenberg

ACS Pharmacology & Translational Science 2021 DOI: 10.1021/acsptsci.0c00171 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Topics Psilocybin
Keywords Indigenous Intellectual property Environmental ethics Traditional knowledge Intangible cultural heritage Creativity Public relations
Citations 54
Key findings Mazatec indigenous communities are excluded from patents on Psilocybe mushroom compounds, contrary to international treaties on indigenous cultural heritage rights.

Abstract

Since a 1957 exposé in Life Magazine, chemical compounds derived from Psilocybe mushrooms have been the focus of dozens of attempted and successful patents, most recently to treat depression. Regrettably, the Mazatec indigenous communities who stewarded these traditional medicines for millenia are not party to any of these patents, despite a number of international treaties asserting indigenous rights to their intangible cultural heritage.

Comparable studies

Other narrative reviews on psilocybin, most cited first.

Citations in the library

Explore topics